Sunshine Biopharma Inc. (SBFMW) Net income 2016–2025
Sunshine Biopharma Inc. (SBFMW) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$6.0MFY2025 · since FY2016: -$3.5M → -$6.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.0M | -16.4% |
| FY2024 | -$5.1M | -13.9% |
| FY2023 | -$4.5M | +83.2% |
| FY2022 | -$26.7M | -115.0% |
| FY2021 | -$12.4M | -346.7% |
| FY2020 | -$2.8M | -67.7% |
| FY2019 | -$1.7M | +23.0% |
| FY2018 | -$2.2M | -107.3% |
| FY2017 | -$1.0M | +70.3% |
| FY2016 | -$3.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SBFMW financial trends
SBFMW RevenueSBFMW Net marginSBFMW Gross profitSBFMW Gross marginSBFMW Operating incomeSBFMW Operating marginSBFMW Operating cash flowSBFMW Free cash flowSBFMW Capital expendituresSBFMW Return on equitySBFMW Stock buybacksSBFMW Dividends paidSBFMW Total assetsSBFMW Total liabilitiesSBFMW Shareholders’ equitySBFMW overview →